Although our previous study has demonstrated that ISG12a is highly expressed in TRAIL‐sensitive hepatoma cells and enhances TRAIL‐induced apoptosis, the downstream mechanisms by which ISG12a increases TRAIL activity still remain unclear. This evidence concerns the gene IFI27 and hepatocellular carcinoma.